Parameter |
Group A Treated patients N:32 |
Group B Non treated patients N:25 |
P-Value |
Age[mean+SD] |
47.12± 6.89 |
48.23± 5.6 |
0.1 |
Male n(%) |
20(62.5%) |
14(56%) |
0.2 |
Female n(%) |
12(37.5%) |
11(44%) |
0.3 |
Jaundice n(%) |
0 |
0 |
|
Hepatomeglyn(%) |
23(71.8%) |
20(80.0%) |
0.2 |
Splenomegaly n(%) |
2(6.25%) |
5(20.0%) |
0.06 |
AST |
45.44± 4.77 |
110.38± 19.83 |
0.0001 |
ALT |
47.45± 3.72 |
114.38± 33.01 |
0.0001 |
|